The Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck Cancer

In Silico Modeling of the Molecular Interactions of Antacid Medication with the Endothelium: Novel Therapeutic Implications in Head and Neck Carcinomas

(2017) M. Matossian et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma

(2015) Ting Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

ImmuSort, a database on gene plasticity and electronic sorting for immune cells

(2015) Pingzhang Wang et al.   Scientific Reports

Proton Pump Inhibitors and Histamine 2 Blockers Are Associated with Improved Overall Survival in Patients with Head and Neck Squamous Carcinoma

(2014) S. Papagerakis et al.   Cancer Prevention Research

Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)

(2014) Juan Ren et al.   CURRENT PHARMACEUTICAL DESIGN

ImmuCo: a database of gene co-expression in immune cells

(2014) Pingzhang Wang et al.   NUCLEIC ACIDS RESEARCH

Continuous Taurocholic Acid Exposure Promotes Esophageal Squamous Cell Carcinoma Progression Due to Reduced Cell Loss Resulting from Enhanced Vascular Development

(2014) Sho Sato et al.   PLoS One

Identification of GPR65, a novel regulator of matrix metalloproteinases using high through-put screening

(2013) Hongbo Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Combination antiangiogenic therapy and radiation in head and neck cancers

(2013) Heng-Wei Hsu et al.   ORAL ONCOLOGY

Acidosis Activation of the Proton-Sensing GPR4 Receptor Stimulates Vascular Endothelial Cell Inflammatory Responses Revealed by Transcriptome Analysis

(2013) Lixue Dong et al.   PLoS One

Acidic tumor microenvironment and pH-sensing G protein-coupled receptors

(2013) Calvin R. Justus et al.   Frontiers in Physiology

Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck

(2012) A. Argiris et al.   ANNALS OF ONCOLOGY

A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer

(2012) Matthew G. Fury et al.   CANCER

Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma

(2011) Elizabeth Van Tubergen et al.   CANCER

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours

(2011) Benjamin Beck et al.   NATURE

Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts

(2011) Shousong Cao et al.   ORAL ONCOLOGY

Activation of GPR4 by Acidosis Increases Endothelial Cell Adhesion through the cAMP/Epac Pathway

(2011) Aishe Chen et al.   PLoS One

Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis

(2011) Lin Ge et al.   PLoS One

Human SBK1 is dysregulated in multiple cancers and promotes survival of ovary cancer SK-OV-3 cells

(2010) Pingzhang Wang et al.   MOLECULAR BIOLOGY REPORTS

Interleukin-6 predicts recurrence and survival among head and neck cancer patients

(2008) Sonia A. Duffy et al.   CANCER